semaglutide liver fat reduction Effect of on fatty disease biomarkers in patients with diabetes and obesity Plain language summary about GLP-1 – efficacy of semaglutide and tirzepatide

The single biggest factor in getting great results is following a slow, patient dose escalation starting at 2mg weekly and building up over 12 weeks before reaching your maintenance dose

Personalized micro-dose strategies

Patients using tirzepatide experience improvements in their A1c levels while taking tirzepatide (Mounjaro)

Initially developed for glycemic control in diabetic patients, recent clinical findings have revealed their profound effects on weight loss, cardiovascular health, and metabolic regulation

What SURMOUNT-5 revealed is a meaningful difference in how often those side effects cause patients to stop treatment: GI-related discontinuation was 2.7% with tirzepatide vs